Refresh

Elder Pharmaceuticals Ltd. - Research Center

532322 ELDERPHARM Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Jun ' 14 Jun ' 13 Mar ' 12 Mar ' 11 Mar ' 10
Income

Operating income

483.47 1,233.10 984.69 832.44 702.79
Expenses

Material consumed

324.13 585.21 481.56 378.01 332.58

Manufacturing expenses

7.00 11.09 13.45 18.19 15.31

Personnel expenses

112.39 151.43 108.98 105.30 90.67

Selling expenses

- - - 58.82 54.02

Adminstrative expenses

128.06 216.30 178.54 100.28 80.64

Expenses capitalised

- - - - -

Cost of sales

571.58 964.03 782.53 660.60 573.22

Operating profit

-88.10 269.07 202.16 171.84 129.58

Other recurring income

15.13 26.22 24.31 8.43 7.63

Adjusted PBDIT

-72.97 295.29 226.46 180.27 137.21

Financial expenses

260.06 137.97 89.02 59.29 50.78

Depreciation

29.16 36.52 27.64 26.87 16.77

Other write offs

- - - - -

Adjusted PBT

-362.19 120.79 109.80 94.10 69.65

Tax charges

9.93 21.97 19.44 17.67 9.29

Adjusted PAT

-372.12 98.83 90.37 76.44 60.36

Non recurring items

380.04 -5.09 -6.29 -5.03 -4.97

Other non cash adjustments

- - - -0.61 -

Reported net profit

7.92 93.74 84.07 70.79 55.39

Earnigs before appropriation

224.54 286.62 270.04 263.13 228.93

Equity dividend

- - 5.16 5.16 4.72

Preference dividend

- - - - -

Dividend tax

- - 1.00 1.00 0.94

Retained earnings

224.54 286.62 263.88 256.97 223.28
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com